Servier Symphogen A/S
Advancing innovative antibody therapeutics to improve cancer patient outcomes globally.
Oversigt
- 164
- Medarbejdere
- Ukendt
- Omsætning
- 2000
- Grundlagt
Beskrivelse
Servier Symphogen is the dedicated Antibody Center of Excellence within the global Servier Group, specializing in the discovery and early development of innovative antibody therapeutics. Founded in 2000 and acquired by Servier in 2020, the company focuses primarily on advancing treatments for oncolo...
Tags
Nøgleord
Teknologistak
Virksomhedsoplysninger
- Branche
- Ukendt
- Juridisk form
- A/S
- Momsnummer
- DK10013267
Beslutningstagere
Ingen beslutningstagere fundet endnu
Lignende virksomheder
20 lignende virksomheder i Funnelfeedr
Y-mAbs Therapeutics A/S
12 medarbejdereDeveloping innovative radioimmunotherapy and antibody-based treatments for challenging cancers.
SERVIER DANMARK A/S
5 medarbejdereA global pharmaceutical company focused on cardiovascular and oncology research.
GENMAB A/S
595 medarbejderePioneering biotechnology company developing innovative antibody therapeutics for serious diseases.
BioInvent International Aktiebolag
100–199 medarbejdereClinical-stage company developing novel immuno-oncology antibody therapeutics for cancer.
Chiesi Pharma Danmark, filial af Chiesi Pharma AB
12 medarbejdereInternational pharmaceutical group focused on innovative respiratory and rare diseases.
Udforsk mere
Spørgsmål om Servier Symphogen A/S
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo